Robin Systems Achieves HDP Product Integration Certification for Robin Cloud Platform
May 25, 2017 12:07 pm UTC| Business
SAN JOSE, Calif., May 25, 2017 -- Robin Systems, a company that is transforming the enterprise with its innovative Robin Cloud Platform (RCP), today announced that it has successfully achieved Hortonworks’ Product...
Robin Systems Achieves HDP Product Integration Certification for Robin Cloud Platform
May 25, 2017 12:07 pm UTC| Business
SAN JOSE, Calif., May 25, 2017 -- Robin Systems, a company that is transforming the enterprise with its innovative Robin Cloud Platform (RCP), today announced that it has successfully achieved Hortonworks’ Product...
CytomX to Present at the Jefferies 2017 Global Healthcare Conference
May 25, 2017 12:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 25, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the...
CytomX to Present at the Jefferies 2017 Global Healthcare Conference
May 25, 2017 12:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 25, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the...
CytomX to Present at the Jefferies 2017 Global Healthcare Conference
May 25, 2017 12:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 25, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the...
CytomX to Present at the Jefferies 2017 Global Healthcare Conference
May 25, 2017 12:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 25, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the...
CytomX to Present at the Jefferies 2017 Global Healthcare Conference
May 25, 2017 12:07 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 25, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the...